Opportunities to engage with STAT reporters and leading industry experts
Every week, STAT+ subscribers get access to exclusive virtual conversations with biotech, pharma and health tech leaders hosted Tuesdays at 1 p.m. ET. Register for this month’s conversations, brought to you by PRA Health Sciences, below. And don’t forget you can view past conversations here, as well.
Sponsored By
MARCH 2, 2021
The hidden impacts of the Covid-19 pandemic
- Usha Lee McFarling, Los Angeles correspondent, STAT
- Rick Berke, co-founder and executive editor, STAT (moderator)
- Sponsor Introduction: Brandon Early, vice president for project delivery, PRA Health Sciences
MARCH 9, 2021
An on-the-ground look at racial disparities in vaccine distribution
- Olivia Goldhill, investigative reporter, STAT
- Bethany Mollenkof, visiting Nieman Fellow, STAT
- Gideon Gil, managing editor, STAT (moderator)
- Sponsor Introduction: Brandon Early, vice president for project delivery, PRA Health Sciences
MARCH 16, 2021
An update on the ongoing Covid-19 vaccine rollout
- Nancy Messonnier, M.D., director, National Center for Immunization and Respiratory Diseases (NCIRD) and senior official for the COVID-19 Vaccine Task Force, Centers for Disease Control and Prevention (CDC)
- Helen Branswell, senior writer, infectious disease, STAT (moderator)
- Sponsor Introduction: Brandon Early, vice president for project delivery, PRA Health Sciences
MARCH 23, 2021
A conversation about the challenges and advances in better hearing technology
- Dwight Crow, co-founder and CEO, Whisper.ai
- Mario Aguilar, health tech correspondent, STAT (moderator)
- Sponsor Introduction: Brandon Early, vice president for project delivery, PRA Health Sciences
MARCH 30, 2021
A conversation on the future of gene therapy
- Katherine A. High, M.D., President, Therapeutics – AskBio
- Damian Garde, national biotech reporter, STAT (moderator)
- Sponsor Introduction: Brandon Early, vice president for project delivery, PRA Health Sciences
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
